Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study-Reference-Cited by-同舟云学术

Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study

Published:2016-03-15 Issue:1 Volume:174 Page:88-101
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Buckstein Rena¹,Wells Richard A.¹,Zhu Nancy²,Leitch Heather A.³,Nevill Thomas J.⁴,Yee Karen W. L.⁵,Leber Brian⁶,Sabloff Mitchell⁷,St. Hilaire Eve⁸,Kumar Rajat⁹,Geddes Michelle¹⁰,Shamy April¹¹,Storring John¹²,Kew Andrea¹³,Elemary Mohamed¹⁴,Levitt Max¹⁵,Lenis Martha¹,Mamedov Alex¹,Zhang Liying¹⁶,Rockwood Ken¹⁷,Alibhai Shabbir M. H.¹⁸

Affiliation:

1. Odette Cancer Centre; Sunnybrook Health Sciences Centre; Toronto ON Canada

2. University of Alberta Hospital; Edmonton AB Canada

3. St. Paul's Hospital and the University of British Columbia; Vancouver BC Canada

4. Vancouver General Hospital; Vancouver BC Canada

5. Princess Margaret Cancer Centre; University Health Network; Toronto ON Canada

6. Juravinski Cancer Center; Hamilton Health Sciences Center; Hamilton ON Canada

7. University of Ottawa and Ottawa Hospital Research Institute; Ottawa ON Canada

8. Centre Hospitalier Universitaire Dr-Georges-L.-Dumont; Moncton QC Canada

9. CancerCare Manitoba; Winnipeg MB Canada

10. Tom Baker Cancer Centre; Calgary AB Canada

11. Jewish General Hospital; Montreal QC Canada

12. McGill University; Health Centre-Royal Victoria Hospital; Montreal QC Canada

13. Queen Elizabeth II Health Sciences Centre; Halifax NS Canada

14. Saskatchewan Cancer Agency; Saskatoon SK Canada

15. Sackler School of Medicine; Tel Aviv University; Tel Aviv Israel

16. Macro STAT; Toronto ON Canada

17. Dalhousie University and Nova Scotia Health Authority; Halifax NS Canada

18. Toronto General Hospital; University Health Network; Toronto ON Canada

Funder

Canadian Institute of Health Research

Celgene

Crashley Estate

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14033/fullpdf

Reference67 articles.

1. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;Journal of the National Cancer Institute,1993

2. Senior adult oncology clinical practice guidelines in oncology;Balducci;Journal of the National Comprehensive Cancer Network,2005

3. Frailty in an older inpatient population: using the clinical frailty scale to predict patient outcomes;Basic;Journal of Aging Health,2015

4. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;New England Journal of Medicine,2011

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic frailty-based determinants of long-term mortality in older patients with newly diagnosed multiple myeloma;2024-08-20

2. Frailty and Cancer Prognosis;Current Oncology Reports;2024-06-12

3. Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS);HemaSphere;2024-05

4. Evaluating targeted therapies in older patients with TP53 -mutated AML;Leukemia & Lymphoma;2024-04-22

5. Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain;American Journal of Hematology;2024-02-27